The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sinopharm Group Co's share price is $14.026.
Sinopharm Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $131.43. Hence, Sinopharm Group Co's PS Ratio for today is 0.11.
Warning Sign:
Sinopharm Group Co Ltd stock PS Ratio (=0.1) is close to 1-year high of 0.11
The historical rank and industry rank for Sinopharm Group Co's PS Ratio or its related term are showing as below:
SHTDY'
s PS Ratio Range Over the Past 10 Years
Min: 0.07 Med: 0.2 Max: 0.42
Current: 0.1
During the past 13 years, Sinopharm Group Co's highest PS Ratio was 0.42. The lowest was 0.07. And the median was 0.20.
SHTDY's PS Ratio is ranked better than 92.52% of 107
companies
in the Medical Distribution industry
Industry Median: 0.52
vs SHTDY: 0.10
Sinopharm Group Co Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Sinopharm Group Co was -2.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 10.40% per year.
During the past 13 years, Sinopharm Group Co's highest 3-Year average Revenue per Share Growth Rate was 33.20% per year. The lowest was 6.30% per year. And the median was 15.00% per year.
Back to Basics: PS Ratio
Sinopharm Group Co PS Ratio Historical Data
The historical data trend for Sinopharm Group Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinopharm Group Co's PS Ratio
For the Medical Distribution subindustry, Sinopharm Group Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co's PS Ratio Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's PS Ratio falls into.
Sinopharm Group Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sinopharm Group Co's Share Price of today is $14.026.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $131.43.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sinopharm Group Co (OTCPK:SHTDY) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sinopharm Group Co PS Ratio Related Terms
Thank you for viewing the detailed overview of Sinopharm Group Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDY has been successfully added to your 